Trials that use: Covariate adjustment
4,539 results
- Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ADRD-PCIndependent statistical analysis of Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00310791).
- Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS): Complete Statistical AnalysisIndependent statistical analysis of Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01764711).
- Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ADVANCEIndependent statistical analysis of the phase 3 ADVANCE trial of peginterferon beta-1a versus placebo in relapsing multiple sclerosis, covering negative binomial rate ratios for annualized relapse rate, Cox hazard ratios, lesion mean…
- ADVANCEIndependent statistical analysis of Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02499679).
- Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences: Complete Statistical AnalysisIndependent statistical analysis of Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences: primary endpoint results, effect estimate with confidence…
- ADvantageIndependent statistical analysis of A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine: primary endpoint…
- AdvantageIndependent statistical analysis of Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint…
- ADVISEIndependent statistical analysis of A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- AEGEANIndependent statistical analysis of Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AEGiSIndependent statistical analysis of Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- AEROBICIndependent statistical analysis of Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AESOPS-T1Independent statistical analysis of Application of Economics & Social Psychology to Improve Opioid Prescribing Safety Trial 1: EHR Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Afatinib in Subjects With Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Afatinib in Subjects With Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096718).
- AFCAREIndependent statistical analysis of Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- AFEQTIndependent statistical analysis of Colorectal Cancer Metastatic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670721).
- AFFILIATEIndependent statistical analysis of Effects of Oral Sildenafil on Mortality in Adults With PAH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02060487).
- AGATE-1Independent statistical analysis of A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and…
- AGAVE-201Independent statistical analysis of A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01530880).
- Aging and Estrogen on Cortical Function: Complete Statistical AnalysisIndependent statistical analysis of Aging and Estrogen on Cortical Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01268046).
- AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02161146).
- AGREEIndependent statistical analysis of MPC-004 for the Treatment of an Acute Gout Flare: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506883).
- AiME – 13Independent statistical analysis of A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance…
- Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01592760).
- Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath: Complete Statistical AnalysisIndependent statistical analysis of Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness…
- Alcohol and Breast Cancer (ABC) Trial: Complete Statistical AnalysisIndependent statistical analysis of Alcohol and Breast Cancer (ABC) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05423730).
- Alemtuzumab + Rituximab Consolidation in CLL: Complete Statistical AnalysisIndependent statistical analysis of Alemtuzumab + Rituximab Consolidation in CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00771602).
- ALFSG-MBTIndependent statistical analysis of 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Algorithm for Predicting the Unfavorable Course of Sepsis in Children: Complete Statistical AnalysisIndependent statistical analysis of Algorithm for Predicting the Unfavorable Course of Sepsis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05908162).
- ALIGN: Aligning Medications With What Matters Most (Demonstration): Complete Statistical AnalysisIndependent statistical analysis of ALIGN: Aligning Medications With What Matters Most (Demonstration): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06335953).
- Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer: primary endpoint…
- Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus: Complete Statistical AnalysisIndependent statistical analysis of Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults: Complete Statistical AnalysisIndependent statistical analysis of ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Alkali Therapy in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Alkali Therapy in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01452412).
- ALLAYIndependent statistical analysis of Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension: primary endpoint results, effect estimate with confidence…
- ALLAY-LID-IIndependent statistical analysis of Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ALLEGRO-2b/3Independent statistical analysis of PF-06651600 for the Treatment of Alopecia Areata: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03732807).
- Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3): Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Alpha-1 Carrier Genomics Study: Complete Statistical AnalysisIndependent statistical analysis of Alpha-1 Carrier Genomics Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02810327).
- ALTA-3Independent statistical analysis of A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Altering Activation Patterns Post-stroke: Complete Statistical AnalysisIndependent statistical analysis of Altering Activation Patterns Post-stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02418949).